Glaxo provided the MHRA with data from clinical trials confirming that patients under 18 had a higher risk of suicidal behaviour if they were treated with Paxil, which is known as Seroxat in the UK,
read more » Discuss Add this link to...Bury Add to:
| Bookmarks